All Resources

Slide deck explaining the basics of insulin secretion and defining its role in diabetes.

Slide deck defining glycemic variability, and explaining how to monitor it in clinical practice

Slide deck explaining the importance of exercise for people with type 1 diabetes

An infographic exploring how to differentiate T1D from T2D, which is essential to prevent misdiagnosis and associated complications.  

Explore the stages of type 1 diabetes

Overview of the factors playing a role in the etiology of T1D.

Explore how clinical outcomes are impacted by screening and monitoring

The number, type, and titer of islet autoantibodies detected in T1D screening tests provide valuable information about potential progression to clinical T1D. 

Expert consensus on monitoring individuals with T1D islet autoantibodies: detection, monitoring frequency, and psychosocial support for managing autoimmune T1D.

Expert consensus on monitoring individuals with T1D islet autoantibodies: detection, monitoring frequency, and psychosocial support for managing autoimmune T1D.

T1D is an autoimmune disease whereby autoreactive T-cells drive progressive beta-cell damage and destruction, ultimately leading to insulin deficiency, dysglycemia, and hyperglycemia. 

Screening for autoimmune T1D involves testing for autoantibodies that are markers of destruction of insulin-producing beta cells.